Overview

Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas

Status:
Completed
Trial end date:
2013-04-09
Target enrollment:
Participant gender:
Summary
Phase III Metastatic Pancreatic Cancer
Phase:
Phase 3
Details
Lead Sponsor:
Celgene
Celgene Corporation
Treatments:
Albumin-Bound Paclitaxel
Gemcitabine
Paclitaxel
Pancrelipase